From cerebral embolic protection to patient-oriented neurological protection after transcatheter aortic valve implantation

Q: What is the clinical evidence from this study?

Study design: Editorial. Population: Severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI). Intervention: Patient-oriented neurological protection / Cerebral embolic protection.

Q: What does this research mean for the field?

Contemporary neurological protection after transcatheter aortic valve implantation should shift from a device-centric approach using routine cerebral embolic protection to an individualized strategy balancing ischemic, embolic, and bleeding risks. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Eliano P. Naverese

doi:10.5603/mrj.114851

January 15, 2026Medical Research JournalOpen Access

From cerebral embolic protection to patient-oriented neurological protection after transcatheter aortic valve implantation

View Full Paper

Ask AI

Bookmark

Share

Key result

Contemporary neurological protection after TAVI should evolve from a predominantly device-oriented concept of cerebral embolic protection to a broader individualized strategy considering both ischemic and bleeding risks.

Key Points

To propose shifting stroke prevention during transcatheter aortic valve implantation from universal mechanical embolic protection devices to an individualized, patient-oriented neurological protection strategy.
Synthesized findings from major randomized clinical trials of cerebral embolic protection devices, including PROTECTED TAVR and BHF PROTECT-TAVI.
Evaluated clinical risk-prediction models such as PREDICT-TAVR alongside pharmacological antithrombotic trials after transcatheter aortic valve implantation.
Routine cerebral embolic protection did not significantly reduce periprocedural stroke in PROTECTED TAVR, nor did it significantly reduce overall or disabling stroke in BHF PROTECT-TAVI.
In patients without an established indication for oral anticoagulation, single antiplatelet therapy reduced bleeding compared with dual antiplatelet therapy without compromising protection against ischemic events.
Adding routine clopidogrel to oral anticoagulation increased bleeding without clinical benefit, confirming that escalating antithrombotic intensity does not improve net clinical outcomes.

PICO

P

Population

Severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI)

I

Intervention / Comparator

Patient-oriented neurological protection / Cerebral embolic protection

Implication

Neurological protection after TAVI should evolve from a predominantly device-oriented concept of cerebral embolic protection to a broader, individualized strategy of patient-oriented neurological protection that includes bleeding prevention and individualized antithrombotic therapy.

Abstract

Not applicable.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Eliano P. Naverese (2026) conducted an editorial in Severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI). Patient-oriented neurological protection / Cerebral embolic protection was evaluated. Contemporary neurological protection after TAVI should evolve from a predominantly device-oriented concept of cerebral embolic protection to a broader individualized strategy considering both ischemic and bleeding risks.

synapsesocial.com/papers/6ace6de6b52af824ab02bc3d https://doi.org/10.5603/mrj.114851

View Full Paper

Ask AI

Bookmark

Share

From cerebral embolic protection to patient-oriented neurological protection after transcatheter aortic valve implantation

Key Points

PICO

Implication

Abstract

Discussion

Cite This Study

From cerebral embolic protection to patient-oriented neurological protection after transcatheter aortic valve implantation

Key Points

PICO

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading